Anaphylaxis
severe allergic reaction

Anaphylaxis is a serious and potentially fatal allergic reaction that can progress rapidly. It typically causes more than one of the following: an itchy rash, throat closing due to swelling that can obstruct or stop breathing; severe tongue swelling that can also interfere with or stop breathing; shortness of breath, vomiting, lightheadedness, loss of consciousness, low blood pressure, and medical shock.
These symptoms typically start in minutes to hours and then increase very rapidly to life-threatening levels. Urgent medical treatment is required to prevent serious harm and death, even if the patient has used an epinephrine autoinjector or has taken other medications in response, and even if symptoms appear to be improving.
Common causes include allergies to insect bites and stings, allergies to foods—including nuts, peanuts, milk, fish, eggs; allergies to medications – including some antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs); or allergies to anaesthetics or latex. Other causes can include physical exercise, and cases may also occur in some people due to escalating reactions to simple throat irritation or may also occur without an obvious reason. The mast cell disease mastocytosis, along with the mast cell disorder mast cell activation syndrome are both capable of triggering anaphylaxis.
The mechanism involves the release of inflammatory mediators in a rapidly escalating cascade from certain types of white blood cells triggered by either immunologic or non-immunologic mechanisms. Diagnosis is based on the presenting symptoms and signs after exposure to a potential allergen or irritant.
The primary treatment of anaphylaxis is epinephrine injection into a muscle, intravenous fluids, then placing the person in a reclining position with feet elevated to help restore normal blood flow.
The public source identifies “Anaphylaxis” as severe allergic reaction. This brief keeps that definition visible, then builds a research path around Anaphylaxis, severe and allergic.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Anaphylaxis”, the useful work is to connect “severe allergic reaction” to the records capable of establishing context and consequence.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Aug 24, 2026. The linked authority identifier is Q168800. The Library of Congress control number is sh85004806. 1 of 1 selected statements include explicit references; 1 carry qualifiers and 0 use preferred rank.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Anaphylaxis”, its source revision and the description used here.
- Expand the search: follow Anaphylaxis primary sources, Anaphylaxis archive and Anaphylaxis research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Anaphylaxis”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “Anaphylaxis” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.